Mo. Appeals Court Upholds $38 Million Depakote Birth Defect Verdict
November 10, 2016
DOCUMENTS
- Opinion
ST. LOUIS — A Missouri appeals court has upheld a $38 million verdict issued in favor of a girl who was born with spina bifida and other birth defects after being exposed to Depakote in utero, finding the evidence supported the jury’s finding that Abbott Laboratories failed to adequately warn doctors that the drug had an increased risk of birth defects versus its competitors and was significantly more dangerous for use in women of childbearing age.
On Nov. 8, the Missouri Court of Appeals, Eastern District, further found the evidence supported the jury’s determination that Abbott’s focus on profit motivated …
UPCOMING CONFERENCES

HarrisMartin's Talcum Powder Litigation Conference: Onward and Upward!
June 15, 2023 - Washington, DC
Fairmont Washington, D.C., Georgetown

HarrisMartin's Camp Lejeune Litigation Conference: The Road to Successful Litigation
June 09, 2023 - Charleston, SC
Charleston School of Law, Sol Blatt Library